In NSCLC, a recent report on the expression of EGFR and downstream-activated signalling factors activated by this receptor (Mukohara et al, 2003) showed that P-ERK is activated in about one-third of NSCLC, as we report in the present study in a much larger series. The gene discussed is MAPK1; the disease is non-small cell lung carcinoma.